Andrew Joseph Muir, MD

Professor of Medicine
Chief, Division of Gastroenterology in the Department of Medicine
Core Faculty in Innovation & Entrepreneurship
Member in the Duke Clinical Research Institute
Campus mail 03137B Hosp South, Durham, NC 27710
Phone (919) 684-2052
Email address andrew.muir@duke.edu
  • Hepatitis C 
  • Primary sclerosing cholangitis
  • Cirrhosis
  • Liver Transplantation
  • Clinical Trials
  • Healthcare disparities in liver disease 
  • Outcomes Research

Education and Training

  • Fellow in Gastroenterology, Medicine, Duke University, 1998 - 2000
  • Chief Medical Resident, Medicine, Duke University, 1997 - 1998
  • Fellow in Gastroenterology, Medicine, Duke University, 1996 - 1997
  • Medical Resident, Medicine, Duke University, 1993 - 1996
  • M.H.S., Duke University, 2001
  • M.D., Duke University, 1993

Publications

Younossi, Zobair M., Andrei Racila, Andrew Muir, Marc Bourliere, Alessandra Mangia, Rafael Esteban, Stefan Zeuzem, et al. “Long-term Patient-Centered Outcomes in Cirrhotic Patients With Chronic Hepatitis C After Achieving Sustained Virologic Response.” Clin Gastroenterol Hepatol 20, no. 2 (February 2022): 438–46. https://doi.org/10.1016/j.cgh.2021.01.026.

PMID
33493697
Full Text

Wegermann, Kara, Julius M. Wilder, Alice Parish, Donna Niedzwiecki, Ziad F. Gellad, Andrew J. Muir, and Yuval A. Patel. “Racial and Socioeconomic Disparities in Utilization of Telehealth in Patients with Liver Disease During COVID-19.” Dig Dis Sci 67, no. 1 (January 2022): 93–99. https://doi.org/10.1007/s10620-021-06842-5.

PMID
33507442
Full Text

Sulkowski, Mark S., Juhi S. Moon, Kenneth E. Sherman, Giuseppe Morelli, Jama M. Darling, Andrew J. Muir, Mandana Khalili, et al. “A Pragmatic, Randomized Controlled Trial of Oral Antivirals for the Treatment of Chronic Hepatitis C: The PRIORITIZE Study.” Hepatology 74, no. 6 (December 2021): 2952–64. https://doi.org/10.1002/hep.32053.

PMID
34255381
Full Text

Henson, Jacqueline B., Yuval A. Patel, and Andrew J. Muir. “Trends in statin utilisation in US adults with non-alcoholic fatty liver disease.” Aliment Pharmacol Ther 54, no. 11–12 (December 2021): 1481–89. https://doi.org/10.1111/apt.16646.

PMID
34653272
Full Text

Hijazi, Ghada, Anna Paschall, Sarah P. Young, Brian Smith, Laura E. Case, Tracy Boggs, Sathya Amarasekara, et al. “A retrospective longitudinal study and comprehensive review of adult patients with glycogen storage disease type III.” Mol Genet Metab Rep 29 (December 2021): 100821. https://doi.org/10.1016/j.ymgmr.2021.100821.

PMID
34820282
Full Text

Brown, Cristal, Nazan Aksan, and Andrew J. Muir. “MELD-Na Accurately Predicts 6-Month Mortality in Patients With Decompensated Cirrhosis: Potential Trigger for Hospice Referral.” Journal of Clinical Gastroenterology, November 22, 2021. https://doi.org/10.1097/mcg.0000000000001642.

PMID
34802021
Full Text

Lee, William M., Wendy C. King, Harry L. A. Janssen, Marc G. Ghany, Robert J. Fontana, Michael Fried, Richard K. Sterling, et al. “Hepatitis B e antigen loss in adults and children with chronic hepatitis B living in North America: A prospective cohort study.” J Viral Hepat 28, no. 11 (November 2021): 1526–38. https://doi.org/10.1111/jvh.13591.

PMID
34355475
Full Text

Sanyal, Arun J., Quentin M. Anstee, Michael Trauner, Eric J. Lawitz, Manal F. Abdelmalek, Dora Ding, Ling Han, et al. “Cirrhosis Regression is Associated with Improved Clinical Outcomes in Patients with Nonalcoholic Steatohepatitis.” In Hepatology, 2021. https://doi.org/10.1002/hep.32204.

PMID
34662449
Full Text

Bailey, Donald E., Andrew J. Muir, Michael P. Cary, Natalie Ammarell, Sarah Seaver, Emily Scirica, Mitch Mah’moud, and Ruth A. Anderson. “Adaptive Challenges and Family Support: Patient Self-Management during Treatment for Chronic Hepatitis C.” Nursing Science Quarterly 34, no. 4 (October 2021): 405–12. https://doi.org/10.1177/08943184211031602.

PMID
34538181
Full Text

Pages